Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Prives

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Cold Spring Harbor Perspectives in Medicine|November 13, 2016
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53Neil T Pfister, Carol Prives
Nature Cell Biology|October 28, 2016
Targeting mutant p53 through the mevalonate pathwayWilliam Freed-Pastor, Carol Prives
Cell|January 18, 2005
P53 and prognosis: new insights and further complexityKaren H Vousden, Carol Prives
Cell|August 10, 2010
Noncoding RNAs: the missing "linc" in p53-mediated repressionAnthony M Barsotti, Carol Prives
Oncotarget|April 30, 2016
Chromatin dysregulation by mutant p53Neil T Pfister, Carol Prives
Molecular Cell|September 20, 2005
The continuing saga of p53--more sleepless nights aheadCarol Prives, James J Manfredi
Cancer Cell|September 9, 2006
Mutant p53 gain of function: the NF-Y connectionMelissa J Peart, Carol Prives
Aging|July 27, 2010
P53 and aging: A fresh look at an old paradigmMasha V Poyurovsky, Carol Prives
Nature|September 3, 2015
Cancer: Mutant p53 and chromatin regulationCarol Prives, Scott W Lowe
Genes & Development|January 19, 2006
Unleashing the power of p53: lessons from mice and menMasha V Poyurovsky, Carol Prives
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Cold Spring Harbor Perspectives in Medicine|November 13, 2016
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53Neil T Pfister, Carol Prives
Nature Cell Biology|October 28, 2016
Targeting mutant p53 through the mevalonate pathwayWilliam Freed-Pastor, Carol Prives
Cell|January 18, 2005
P53 and prognosis: new insights and further complexityKaren H Vousden, Carol Prives
Cell|August 10, 2010
Noncoding RNAs: the missing "linc" in p53-mediated repressionAnthony M Barsotti, Carol Prives
Oncotarget|April 30, 2016
Chromatin dysregulation by mutant p53Neil T Pfister, Carol Prives
Molecular Cell|September 20, 2005
The continuing saga of p53--more sleepless nights aheadCarol Prives, James J Manfredi
Cancer Cell|September 9, 2006
Mutant p53 gain of function: the NF-Y connectionMelissa J Peart, Carol Prives
Aging|July 27, 2010
P53 and aging: A fresh look at an old paradigmMasha V Poyurovsky, Carol Prives
Nature|September 3, 2015
Cancer: Mutant p53 and chromatin regulationCarol Prives, Scott W Lowe
Genes & Development|January 19, 2006
Unleashing the power of p53: lessons from mice and menMasha V Poyurovsky, Carol Prives
Pageof 13